# Expanded Access to Upadacitinib

> **NCT04159597** · — · AVAILABLE · sponsor: **AbbVie**

## Conditions studied

- Crohn Disease
- Ulcerative Colitis
- Idiopathic Arthritis (Including sJIA, pJIA, or JPsA)
- Atopic Dermatitis

## Interventions

- **DRUG:** Upadacitinib

## Key facts

- **NCT ID:** NCT04159597
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159597, "Expanded Access to Upadacitinib". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04159597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*